Amgen, Inc. (AMGN)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Amgen, Inc. (AMGN)
Go deeper and ask any question about AMGN
Company Performance
Current Price
as of Sep 13, 2024$332.45
P/E Ratio
57.28
Market Cap
$178.64B
Description
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Metrics
Overview
- HQThousand Oaks, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerAMGN
- Price$332.45+0.72%
Trading Information
- Market Cap$178.64B
- Float99.76%
- Average Daily Volume (1m)1,660,630
- Average Daily Volume (3m)2,062,600
- EPS$5.85
Company
- Revenue$30.74B
- Rev Growth (1yr)19.90%
- Net Income$746.00M
- Gross Margin61.17%
- EBITDA Margin39.05%
- EBITDA$3.25B
- EV$222.38B
- EV/Revenue7.24
- P/E57.28
- P/S5.85
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset